ResearcherCentro Nacional de BiotecnologíaActive in the last 2 years

Nuria Lafuente‐Gómez

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9269-3163; OpenAlex author ID A5048308458. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2025: 2 papers

Papers 2

Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2025.113791 ↗
Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic Cancer. Co-author DOI 10.1021/acsami.4c16129 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ibane Abasolo Olaortua · 2 shared papers, 2025 · strength 0.41
- Paper Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic can… DOI 10.1016/j.jconrel.2025.113791 ↗
- Paper Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic Cancer. DOI 10.1021/acsami.4c16129 ↗
Álvaro Somoza · 2 shared papers, 2025 · strength 0.41
- Paper Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic can… DOI 10.1016/j.jconrel.2025.113791 ↗
- Paper Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic Cancer. DOI 10.1021/acsami.4c16129 ↗
Zamira V. Díaz‐Riascos · 2 shared papers, 2025 · strength 0.41
- Paper Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic can… DOI 10.1016/j.jconrel.2025.113791 ↗
- Paper Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic Cancer. DOI 10.1021/acsami.4c16129 ↗
Adriele Prina‐Mello · 1 shared paper, 2025 · strength 0.18
- Paper Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic Cancer. DOI 10.1021/acsami.4c16129 ↗
Francesca Sarno · 1 shared paper, 2025 · strength 0.18
- Paper Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic Cancer. DOI 10.1021/acsami.4c16129 ↗
Manuel M. Hidalgo · 1 shared paper, 2025 · strength 0.18
- Paper Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic Cancer. DOI 10.1021/acsami.4c16129 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.